Try our Advanced Search for more refined results
CytomX Therapeutics Inc.
-
Misc | Filed: January 26, 2024 | Entered: January 26, 2024 Vytacera Bio, LLC v. CytomX Therapeutics, Inc.
Patent | Delaware
Response to Objections
RESPONSE TO OBJECTIONS by CytomX Therapeutics, Inc. re 180 Objections, 178 REPORT AND RECOMMENDATIONS re 164 MOTION for Judgment on the Pleadings Pursuant to Rule 12(c) filed by CytomX Therapeutics, Inc.. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing cons . (Kraning, Casey)
-
Utility | Filed: January 08, 2024 | Entered: January 08, 2024 Vytacera Bio, LLC v. CytomX Therapeutics, Inc.
Patent | Delaware
Case Assigned/Reassigned
Case Reassigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (rjb)
-
Misc | Filed: December 12, 2023 | Entered: December 12, 2023 Vytacera Bio, LLC v. CytomX Therapeutics, Inc.
Patent | Delaware
Objections
OBJECTIONS by Vytacera Bio, LLC to 178 REPORT AND RECOMMENDATIONS re 164 MOTION for Judgment on the Pleadings Pursuant to Rule 12(c) filed by CytomX Therapeutics, Inc.. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing cons . (Stamoulis, Stamatios)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login